Figure 1.
Distinguishing features of the US Food and Drug Administration–approved CAR T-cell constructs and updated outcomes from the pivotal trials.25,26,28,36

Distinguishing features of the US Food and Drug Administration–approved CAR T-cell constructs and updated outcomes from the pivotal trials.25,26,28,36

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal